Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gx Media is a specialized in vitro fertilization (IVF) culture media system developed by Vitrolife that incorporates a triple antioxidant combination of acetyl-L-carnitine, alpha-lipoic acid, and N-acetyl-L-cysteine. Launched in 2018, the system includes products such as Gx-MOPS PLUS, Gx-IVF, and Gx-TL, which are designed to provide a protective barrier against oxidative stress during gamete handling, fertilization, and embryo culture. By scavenging reactive oxygen species (ROS), these antioxidants mimic the natural in vivo environment to protect embryos from damage, improve embryo viability and development, and ultimately enhance clinical pregnancy rates for IVF patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gx Media.